Logo image of CODX

CO-DIAGNOSTICS INC (CODX) Stock Fundamental Analysis

NASDAQ:CODX - Nasdaq - US1897631057 - Common Stock - Currency: USD

0.2883  -0.01 (-2.07%)

After market: 0.29 +0 (+0.59%)

Fundamental Rating

4

CODX gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 187 industry peers in the Health Care Equipment & Supplies industry. CODX scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CODX is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

CODX had negative earnings in the past year.
CODX had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CODX reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: CODX reported negative operating cash flow in multiple years.
CODX Yearly Net Income VS EBIT VS OCF VS FCFCODX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M

1.2 Ratios

The Return On Assets of CODX (-65.02%) is worse than 71.66% of its industry peers.
CODX has a Return On Equity of -74.83%. This is comparable to the rest of the industry: CODX outperforms 40.64% of its industry peers.
Industry RankSector Rank
ROA -65.02%
ROE -74.83%
ROIC N/A
ROA(3y)-35.82%
ROA(5y)-4.97%
ROE(3y)-40.94%
ROE(5y)-6.37%
ROIC(3y)N/A
ROIC(5y)N/A
CODX Yearly ROA, ROE, ROICCODX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400 -400 600

1.3 Margins

The Gross Margin of CODX (77.52%) is better than 90.91% of its industry peers.
In the last couple of years the Gross Margin of CODX has grown nicely.
CODX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 77.52%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.47%
GM growth 5Y9.36%
CODX Yearly Profit, Operating, Gross MarginsCODX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20K -40K -60K

6

2. Health

2.1 Basic Checks

CODX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CODX has been increased compared to 1 year ago.
CODX has more shares outstanding than it did 5 years ago.
There is no outstanding debt for CODX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CODX Yearly Shares OutstandingCODX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
CODX Yearly Total Debt VS Total AssetsCODX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

Based on the Altman-Z score of -2.04, we must say that CODX is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -2.04, CODX is doing worse than 64.71% of the companies in the same industry.
There is no outstanding debt for CODX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -2.04
ROIC/WACCN/A
WACC8.99%
CODX Yearly LT Debt VS Equity VS FCFCODX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

CODX has a Current Ratio of 4.43. This indicates that CODX is financially healthy and has no problem in meeting its short term obligations.
CODX has a Current ratio of 4.43. This is in the better half of the industry: CODX outperforms 68.45% of its industry peers.
CODX has a Quick Ratio of 4.23. This indicates that CODX is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 4.23, CODX is doing good in the industry, outperforming 74.87% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.43
Quick Ratio 4.23
CODX Yearly Current Assets VS Current LiabilitesCODX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

6

3. Growth

3.1 Past

CODX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 19.70%, which is quite good.
Looking at the last year, CODX shows a very negative growth in Revenue. The Revenue has decreased by -47.67% in the last year.
CODX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 79.52% yearly.
EPS 1Y (TTM)19.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.58%
Revenue 1Y (TTM)-47.67%
Revenue growth 3Y-65.8%
Revenue growth 5Y79.52%
Sales Q2Q%-89.25%

3.2 Future

The Earnings Per Share is expected to grow by 19.61% on average over the next years. This is quite good.
CODX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 171.12% yearly.
EPS Next Y3.42%
EPS Next 2Y27.31%
EPS Next 3Y19.61%
EPS Next 5YN/A
Revenue Next Year-88.53%
Revenue Next 2Y-59.63%
Revenue Next 3Y111.18%
Revenue Next 5Y171.12%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CODX Yearly Revenue VS EstimatesCODX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B
CODX Yearly EPS VS EstimatesCODX Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 1 -1 1.5

0

4. Valuation

4.1 Price/Earnings Ratio

CODX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year CODX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CODX Price Earnings VS Forward Price EarningsCODX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CODX Per share dataCODX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 -1

4.3 Compensation for Growth

CODX's earnings are expected to grow with 19.61% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.31%
EPS Next 3Y19.61%

0

5. Dividend

5.1 Amount

No dividends for CODX!.
Industry RankSector Rank
Dividend Yield N/A

CO-DIAGNOSTICS INC

NASDAQ:CODX (7/23/2025, 8:13:33 PM)

After market: 0.29 +0 (+0.59%)

0.2883

-0.01 (-2.07%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-08 2025-05-08/amc
Earnings (Next)08-07 2025-08-07
Inst Owners17.44%
Inst Owner Change0%
Ins Owners9%
Ins Owner Change5.49%
Market Cap9.72M
Analysts80
Price Target5.61 (1845.89%)
Short Float %0.92%
Short Ratio0.39
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)12.45%
Min EPS beat(2)-3.81%
Max EPS beat(2)28.7%
EPS beat(4)3
Avg EPS beat(4)22.36%
Min EPS beat(4)-3.81%
Max EPS beat(4)59.63%
EPS beat(8)4
Avg EPS beat(8)-11.83%
EPS beat(12)6
Avg EPS beat(12)-49.97%
EPS beat(16)10
Avg EPS beat(16)-17.23%
Revenue beat(2)0
Avg Revenue beat(2)-73.95%
Min Revenue beat(2)-86.85%
Max Revenue beat(2)-61.05%
Revenue beat(4)2
Avg Revenue beat(4)128.59%
Min Revenue beat(4)-86.85%
Max Revenue beat(4)594.64%
Revenue beat(8)3
Avg Revenue beat(8)183.6%
Revenue beat(12)3
Avg Revenue beat(12)102.82%
Revenue beat(16)6
Avg Revenue beat(16)80.32%
PT rev (1m)0%
PT rev (3m)450%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-87.88%
EPS NY rev (1m)0%
EPS NY rev (3m)-17.58%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-60%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-68.33%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.78
P/FCF N/A
P/OCF N/A
P/B 0.2
P/tB 0.45
EV/EBITDA N/A
EPS(TTM)-1.06
EYN/A
EPS(NY)-0.43
Fwd EYN/A
FCF(TTM)-0.89
FCFYN/A
OCF(TTM)-0.87
OCFYN/A
SpS0.1
BVpS1.42
TBVpS0.65
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -65.02%
ROE -74.83%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 77.52%
FCFM N/A
ROA(3y)-35.82%
ROA(5y)-4.97%
ROE(3y)-40.94%
ROE(5y)-6.37%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.47%
GM growth 5Y9.36%
F-Score3
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 33%
Cap/Sales 12.52%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.43
Quick Ratio 4.23
Altman-Z -2.04
F-Score3
WACC8.99%
ROIC/WACCN/A
Cap/Depr(3y)92.34%
Cap/Depr(5y)204.81%
Cap/Sales(3y)14.45%
Cap/Sales(5y)9.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)19.7%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.58%
EPS Next Y3.42%
EPS Next 2Y27.31%
EPS Next 3Y19.61%
EPS Next 5YN/A
Revenue 1Y (TTM)-47.67%
Revenue growth 3Y-65.8%
Revenue growth 5Y79.52%
Sales Q2Q%-89.25%
Revenue Next Year-88.53%
Revenue Next 2Y-59.63%
Revenue Next 3Y111.18%
Revenue Next 5Y171.12%
EBIT growth 1Y10.81%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-275.44%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-336.35%
OCF growth 3YN/A
OCF growth 5YN/A